225 related articles for article (PubMed ID: 29042316)
1. Repeated exposure to 3,4-methylenedioxypyrovalerone and cocaine produces locomotor sensitization with minimal effects on brain monoamines.
Kohler RJ; Perrine SA; Baker LE
Neuropharmacology; 2018 May; 134(Pt A):22-27. PubMed ID: 29042316
[TBL] [Abstract][Full Text] [Related]
2. Discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) and structurally related synthetic cathinones.
Seaman RW; Doyle MR; Sulima A; Rice KC; Collins GT
Behav Pharmacol; 2021 Aug; 32(5):357-367. PubMed ID: 33587482
[TBL] [Abstract][Full Text] [Related]
3. Effects of MDPV on dopamine transporter regulation in male rats. Comparison with cocaine.
Lopez-Arnau R; Duart-Castells L; Aster B; Camarasa J; Escubedo E; Pubill D
Psychopharmacology (Berl); 2019 Mar; 236(3):925-938. PubMed ID: 30284596
[TBL] [Abstract][Full Text] [Related]
4. Sensitization to the locomotor stimulant effects of "bath salt" constituents, 4-methylmethcathinone (4-MMC) and 3,4-methylenedioxypyrovalerone (MDPV), in male Sprague-Dawley rats.
Berquist MD; Traxler HK; Mahler AM; Baker LE
Drug Alcohol Depend; 2016 Jul; 164():128-134. PubMed ID: 27181413
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic Effects of Major Bath Salt Constituents 3,4-Methylenedioxypyrovalerone (MDPV), Mephedrone, and Methylone Are Enhanced Following Co-exposure.
Allen SA; Tran LH; Oakes HV; Brown RW; Pond BB
Neurotox Res; 2019 Jul; 36(1):132-143. PubMed ID: 30879275
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).
Marusich JA; Antonazzo KR; Wiley JL; Blough BE; Partilla JS; Baumann MH
Neuropharmacology; 2014 Dec; 87():206-13. PubMed ID: 24594476
[TBL] [Abstract][Full Text] [Related]
7. Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.
Baumann MH; Partilla JS; Lehner KR; Thorndike EB; Hoffman AF; Holy M; Rothman RB; Goldberg SR; Lupica CR; Sitte HH; Brandt SD; Tella SR; Cozzi NV; Schindler CW
Neuropsychopharmacology; 2013 Mar; 38(4):552-62. PubMed ID: 23072836
[TBL] [Abstract][Full Text] [Related]
8. Role of monoaminergic systems and ambient temperature in bath salts constituent 3,4-methylenedioxypyrovalerone (MDPV)-elicited hyperthermia and locomotor stimulation in mice.
Gannon BM; Williamson A; Rice KC; Fantegrossi WE
Neuropharmacology; 2018 May; 134(Pt A):13-21. PubMed ID: 28887185
[TBL] [Abstract][Full Text] [Related]
9. Contribution of monoaminergic mechanisms to the discriminative stimulus effects of 3,4-methylenedioxypyrovalerone (MDPV) in Sprague-Dawley rats.
Risca HI; Baker LE
Psychopharmacology (Berl); 2019 Mar; 236(3):963-971. PubMed ID: 30554256
[TBL] [Abstract][Full Text] [Related]
10. Characterization of 3,4-methylenedioxypyrovalerone discrimination in female Sprague-Dawley rats.
Thomas AM; Cargile KJ; Lunn JA; Baker LE
Behav Pharmacol; 2021 Sep; 32(6):524-532. PubMed ID: 34397448
[TBL] [Abstract][Full Text] [Related]
11. Acute and chronic neurobehavioral effects of the designer drug and bath salt constituent 3,4-methylenedioxypyrovalerone in the rat.
Atehortua-Martinez LA; Masniere C; Campolongo P; Chasseigneaux S; Callebert J; Zwergel C; Mai A; Laplanche JL; Chen H; Etheve-Quelquejeu M; Mégarbane B; Benturquia N
J Psychopharmacol; 2019 Mar; 33(3):392-405. PubMed ID: 30644332
[TBL] [Abstract][Full Text] [Related]
12. Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator.
Gregg RA; Hicks C; Nayak SU; Tallarida CS; Nucero P; Smith GR; Reitz AB; Rawls SM
Neuropharmacology; 2016 Sep; 108():111-9. PubMed ID: 27085607
[TBL] [Abstract][Full Text] [Related]
13. Functional connectivity, behavioral and dopaminergic alterations 24 hours following acute exposure to synthetic bath salt drug methylenedioxypyrovalerone.
Colon-Perez LM; Pino JA; Saha K; Pompilus M; Kaplitz S; Choudhury N; Jagnarine DA; Geste JR; Levin BA; Wilks I; Setlow B; Bruijnzeel AW; Khoshbouei H; Torres GE; Febo M
Neuropharmacology; 2018 Jul; 137():178-193. PubMed ID: 29729891
[TBL] [Abstract][Full Text] [Related]
14. 7,8-Dihydroxyflavone blocks the development of behavioral sensitization to MDPV, but not to cocaine: Differential role of the BDNF-TrkB pathway.
Duart-Castells L; López-Arnau R; Vizcaíno S; Camarasa J; Pubill D; Escubedo E
Biochem Pharmacol; 2019 May; 163():84-93. PubMed ID: 30738029
[TBL] [Abstract][Full Text] [Related]
15. Amphetamine maintenance differentially modulates effects of cocaine, methylenedioxypyrovalerone (MDPV), and methamphetamine on intracranial self-stimulation and nucleus accumbens dopamine in rats.
Johnson AR; Banks ML; Selley DE; Negus SS
Neuropsychopharmacology; 2018 Jul; 43(8):1753-1762. PubMed ID: 29703999
[TBL] [Abstract][Full Text] [Related]
16. Reinforcing and neurochemical effects of the "bath salts" constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats.
Schindler CW; Thorndike EB; Goldberg SR; Lehner KR; Cozzi NV; Brandt SD; Baumann MH
Psychopharmacology (Berl); 2016 May; 233(10):1981-90. PubMed ID: 26319160
[TBL] [Abstract][Full Text] [Related]
17. Conditioned place preference following concurrent treatment with 3, 4-methylenedioxypyrovalerone (MDPV) and methamphetamine in male and female Sprague-Dawley rats.
Risca HI; Zuarth-Gonzalez JD; Baker LE
Pharmacol Biochem Behav; 2020 Nov; 198():173032. PubMed ID: 32888971
[TBL] [Abstract][Full Text] [Related]
18. Repeated administration of synthetic cathinone 3,4-methylenedioxypyrovalerone persistently increases impulsive choice in rats.
Hyatt WS; Berquist MD; Chitre NM; Russell LN; Rice KC; Murnane KS; Fantegrossi WE
Behav Pharmacol; 2019 Oct; 30(7):555-565. PubMed ID: 31211703
[TBL] [Abstract][Full Text] [Related]
19. Comparing rewarding and reinforcing properties between 'bath salt' 3,4-methylenedioxypyrovalerone (MDPV) and cocaine using ultrasonic vocalizations in rats.
Simmons SJ; Gregg RA; Tran FH; Mo L; von Weltin E; Barker DJ; Gentile TA; Watterson LR; Rawls SM; Muschamp JW
Addict Biol; 2018 Jan; 23(1):102-110. PubMed ID: 27910188
[TBL] [Abstract][Full Text] [Related]
20. Changes in CREB and deltaFosB are associated with the behavioural sensitization induced by methylenedioxypyrovalerone.
Buenrostro-Jáuregui M; Ciudad-Roberts A; Moreno J; Muñoz-Villegas P; López-Arnau R; Pubill D; Escubedo E; Camarasa J
J Psychopharmacol; 2016 Jul; 30(7):707-12. PubMed ID: 27147595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
